Skip to main content
Rebecca Olin, MD, Oncology, San Francisco, CA

RebeccaLOlinMD

Oncology San Francisco, CA

Hematologic Oncology

Assistant Professor, Medicine, UCSF School of Medicine

Dr. Olin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Olin's full profile

Already have an account?

  • Office

    400 Parnassus Ave
    Box 0324
    San Francisco, CA 94143
    Phone+1 415-353-2063

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2006 - 2009
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2003 - 2006
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2026
  • PA State Medical License
    PA State Medical License 2003 - 2010
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Incidence of Serious Adverse Events, Pneumonitis, Infection and Sepsis in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphom...
    Rebecca L. Olin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Phase 1 Dose Escalation Study of Milademetan in Combination with 5-Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndr...
    Rebecca Olin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative Neoplasms
    Rebecca L. Olin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Friday Scientific Workshop on Hematology and Aging: From Bleeding Disorders to Malignant Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Aging and Hematologic Disorders: Exploring the Evidence 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all